Anti-Arrhythmia Agents

"Anti-Arrhythmia Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.

Descriptor ID	D000889
MeSH Number(s)	D27.505.954.411.097
Concept/Terms	Anti-Arrhythmia Agents Anti-Arrhythmia Agents Agents, Anti-Arrhythmia Anti Arrhythmia Agents Antiarrhythmic Drugs Drugs, Antiarrhythmic Antiarrhythmia Agents Agents, Antiarrhythmia Antiarrhythmia Drugs Drugs, Antiarrhythmia Anti-Arrhythmia Drugs Anti Arrhythmia Drugs Drugs, Anti-Arrhythmia Anti-Arrhythmics Anti Arrhythmics Cardiac Depressants Cardiac Depressants Depressants, Cardiac Myocardial Depressants Depressants, Myocardial Antifibrillatory Agents Antifibrillatory Agents Agents, Antifibrillatory

Below are MeSH descriptors whose meaning is more general than "Anti-Arrhythmia Agents".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Therapeutic Uses [D27.505.954]
Cardiovascular Agents [D27.505.954.411]
Anti-Arrhythmia Agents [D27.505.954.411.097]

Below are MeSH descriptors whose meaning is related to "Anti-Arrhythmia Agents".

Below are MeSH descriptors whose meaning is more specific than "Anti-Arrhythmia Agents".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Anti-Arrhythmia Agents" by people in this website by year, and whether "Anti-Arrhythmia Agents" was a major or minor topic of these publications.

Bar chart showing 69 publications over 27 distinct years, with a maximum of 7 publications in 1996

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1993	1	0	1
1994	1	1	2
1996	4	3	7
1997	4	2	6
1999	4	0	4
2000	0	1	1
2001	2	2	4
2002	1	4	5
2003	0	2	2
2004	1	0	1
2005	1	2	3
2006	1	0	1
2007	0	2	2
2008	1	1	2
2009	1	2	3
2010	0	1	1
2011	2	0	2
2012	2	0	2
2013	0	1	1
2014	1	2	3
2015	1	1	2
2016	3	0	3
2017	0	1	1
2018	1	2	3
2019	1	0	1
2020	1	2	3
2021	2	1	3

Below are the most recent publications written about "Anti-Arrhythmia Agents" by people in Profiles.

Field ME. Intravenous sotalol-A shortcut to success? J Cardiovasc Electrophysiol. 2022 03; 33(3):343-344.

View in: PubMed
Matuskowitz AJ, Weant KA, Gregory H, Field ME, Calhoun C, Bushkar BJ, Hall GA, Caporossi J. Implementation of a Procainamide-Based Cardioversion Strategy for the Management of Recent-Onset Atrial Fibrillation. Adv Emerg Nurs J. 2021 Jul-Sep 01; 43(3):186-193.

View in: PubMed
Field ME, Holmes DN, Page RL, Fonarow GC, Matsouaka RA, Turakhia MP, Lewis WR, Piccini JP. Guideline-Concordant Antiarrhythmic Drug Use in the Get With The Guidelines-Atrial Fibrillation Registry. Circ Arrhythm Electrophysiol. 2021 02; 14(2):e008961.

View in: PubMed
Allana SS, Rajput FA, Smith JW, Lozonschi L, Liou JI, Johnson M, Kohmoto T, Dhingra R. Amiodarone Use Prior to Cardiac Transplant Impacts Early Post-Transplant Survival. Cardiovasc Drugs Ther. 2021 02; 35(1):33-40.

View in: PubMed
Hamstra MS, Pemberton VL, Dagincourt N, Hollenbeck-Pringle D, Trachtenberg FL, Cnota JF, Atz AM, Cappella E, De Nobele S, Grima J, King M, Korsin R, Lambert LM, MacNeal MK, Markham LW, MacCarrick G, Sylvester DM, Walter P, Xu M, Lacro RV. Recruitment, retention, and adherence in a clinical trial: The Pediatric Heart Network's Marfan Trial experience. Clin Trials. 2020 12; 17(6):684-695.

View in: PubMed
Lam PH, Packer M, Gill GS, Wu WC, Levy WC, Zile MR, Brar V, Arundel C, Cheng Y, Singh SN, Allman RM, Fonarow GC, Ahmed A. Digoxin Initiation and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction. Am J Med. 2020 10; 133(10):1187-1194.

View in: PubMed
Elliott PM, Anastasakis A, Asimaki A, Basso C, Bauce B, Brooke MA, Calkins H, Corrado D, Duru F, Green KJ, Judge DP, Kelsell D, Lambiase PD, McKenna WJ, Pilichou K, Protonotarios A, Saffitz JE, Syrris P, Tandri H, Te Riele A, Thiene G, Tsatsopoulou A, van Tintelen JP. Definition and treatment of arrhythmogenic cardiomyopathy: an updated expert panel report. Eur J Heart Fail. 2019 08; 21(8):955-964.

View in: PubMed
Kipp R, Askari M, Fan J, Field ME, Turakhia MP. Real-World Comparison of Classes IC and III Antiarrhythmic Drugs as an Initial Rhythm Control Strategy in Newly Diagnosed Atrial Fibrillation: From the TREAT-AF Study. JACC Clin Electrophysiol. 2019 02; 5(2):231-241.

View in: PubMed
Longino J, Chaddha A, Kalscheur MM, Rikkers AM, Gopal DV, Field ME, Wright JM. Impact of a novel protocol for atrial fibrillation management in outpatient gastrointestinal endoscopic procedures: a retrospective cohort study. BMC Cardiovasc Disord. 2018 09 03; 18(1):179.

View in: PubMed
Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, Deal BJ, Dickfeld T, Field ME, Fonarow GC, Gillis AM, Granger CB, Hammill SC, Hlatky MA, Joglar JA, Kay GN, Matlock DD, Myerburg RJ, Page RL. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2018 10 02; 72(14):e91-e220.

View in: PubMed

People

Explore

Similar Concepts

Top Journals